Market Overview:
The global liothyronine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of thyroid disorders, increasing demand for liothyronine in chemical reagents and pharmaceutical intermediates applications, and growing investments by key players in R&D activities. However, stringent regulatory norms for drug approvals are likely to restrain the growth of the market during the forecast period. Based on type, the global liothyronine market is segmented into purity 97%, purity 98%, purity 99%, and other segments. The purity 97% segment is expected to account for a major share of the global liothyronine market during the forecast period owing to its high demand from end-use industries such as chemical reagents and pharmaceutical intermediates.
Product Definition:
Liothyronine is a synthetic thyroid hormone used to treat hypothyroidism. It is also occasionally used for weight loss and in the treatment of other conditions.
Purity 97%:
Purity 97% is a form of L-tryptophan that has been processed to remove all other amino acids from the molecule. It's appearance as a white powder and its odorless properties make it ideal for use in pharmaceuticals and dietary supplements. Increasing demand for products with natural ingredients is expected to be one of the key drivers for this market over the forecast period.
Purity 98%:
Purity 98% is a raw material used in the production of Liothyronine. It is also known as Levoxyl, Tirosint or N-Tirosin. Purity 98% has been tested and found to be free from all kinds of impurities and contains no other chemical substances than that specified on the label.
Application Insights:
The other application segment includes the use of liothyronine for research purposes and in the treatment of disease. The chemical is used as a chemical reagent in various laboratories across the world. It is also used as an intermediate in drug discovery and development processes by several companies and institutions. However, major applications are found outside these sectors such as pharmaceutical intermediates, where it is utilized to produce thyroid hormones under Good Manufacturing Practice (GMP) conditions.
Liothyronine has been approved by U.S.
Regional Analysis:
Asia Pacific dominated the global Liothyronine market in 2017. The presence of key manufacturers and suppliers coupled with a robust manufacturing base for pharmaceuticals, chemicals, and other industries is expected to drive the regional demand over the forecast period.
China accounted for approximately 45% of Asia Pacific market volume in 2017 owing to its robust production capacity and availability of low-cost raw materials such as triacalcitol as well as labor. Furthermore, increasing healthcare expenditure coupled with growing awareness regarding thyroid disorders is anticipated to fuel growth over the forecast period.
Growth Factors:
- Increasing prevalence of thyroid disorders: The global prevalence of thyroid disorders is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and dietary habits. According to a study by the World Health Organization, the number of people suffering from thyroid disorders is expected to reach more than 717 million by 2020. This will create significant growth opportunities for the Liothyronine market in the coming years.
- Growing awareness about thyroid diseases: There is a growing awareness among people about different types of thyroid diseases and their symptoms. This has led to an increase in the number of patients seeking medical help for diagnosis and treatment of these diseases. This will boost demand for Liothyronine in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Liothyronine Market Research Report
By Type
Purity 97%, Purity 98%, Purity 99%, Other
By Application
Chemical Reagents, Pharmaceutical Intermediates, Other
By Companies
TCI, HBCChem, Toronto Research Chemicals, Waterstone Technology, Alfa Aesar, 3B Scientific, VWR International, Suzhou Ryan Pharmaceutical Technology, J & K SCIENTIFIC, Meryer Chemical Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Liothyronine Market Report Segments:
The global Liothyronine market is segmented on the basis of:
Types
Purity 97%, Purity 98%, Purity 99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chemical Reagents, Pharmaceutical Intermediates, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- TCI
- HBCChem
- Toronto Research Chemicals
- Waterstone Technology
- Alfa Aesar
- 3B Scientific
- VWR International
- Suzhou Ryan Pharmaceutical Technology
- J & K SCIENTIFIC
- Meryer Chemical Technology
Highlights of The Liothyronine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 97%
- Purity 98%
- Purity 99%
- Other
- By Application:
- Chemical Reagents
- Pharmaceutical Intermediates
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liothyronine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liothyronine is a medication used to treat thyroid problems. It works by increasing the amount of thyroid hormone in the body.
Some of the major players in the liothyronine market are TCI, HBCChem, Toronto Research Chemicals, Waterstone Technology, Alfa Aesar, 3B Scientific, VWR International, Suzhou Ryan Pharmaceutical Technology, J & K SCIENTIFIC, Meryer Chemical Technology.
The liothyronine market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Liothyronine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Liothyronine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Liothyronine Market - Supply Chain
4.5. Global Liothyronine Market Forecast
4.5.1. Liothyronine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Liothyronine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Liothyronine Market Absolute $ Opportunity
5. Global Liothyronine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Liothyronine Market Size and Volume Forecast by Type
5.3.1. Purity 97%
5.3.2. Purity 98%
5.3.3. Purity 99%
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Liothyronine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Liothyronine Market Size and Volume Forecast by Application
6.3.1. Chemical Reagents
6.3.2. Pharmaceutical Intermediates
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Liothyronine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Liothyronine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Liothyronine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Liothyronine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Liothyronine Demand Share Forecast, 2019-2029
9. North America Liothyronine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Liothyronine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Liothyronine Market Size and Volume Forecast by Application
9.4.1. Chemical Reagents
9.4.2. Pharmaceutical Intermediates
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Liothyronine Market Size and Volume Forecast by Type
9.7.1. Purity 97%
9.7.2. Purity 98%
9.7.3. Purity 99%
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Liothyronine Demand Share Forecast, 2019-2029
10. Latin America Liothyronine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Liothyronine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Liothyronine Market Size and Volume Forecast by Application
10.4.1. Chemical Reagents
10.4.2. Pharmaceutical Intermediates
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Liothyronine Market Size and Volume Forecast by Type
10.7.1. Purity 97%
10.7.2. Purity 98%
10.7.3. Purity 99%
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Liothyronine Demand Share Forecast, 2019-2029
11. Europe Liothyronine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Liothyronine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Liothyronine Market Size and Volume Forecast by Application
11.4.1. Chemical Reagents
11.4.2. Pharmaceutical Intermediates
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Liothyronine Market Size and Volume Forecast by Type
11.7.1. Purity 97%
11.7.2. Purity 98%
11.7.3. Purity 99%
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Liothyronine Demand Share, 2019-2029
12. Asia Pacific Liothyronine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Liothyronine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Liothyronine Market Size and Volume Forecast by Application
12.4.1. Chemical Reagents
12.4.2. Pharmaceutical Intermediates
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Liothyronine Market Size and Volume Forecast by Type
12.7.1. Purity 97%
12.7.2. Purity 98%
12.7.3. Purity 99%
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Liothyronine Demand Share, 2019-2029
13. Middle East & Africa Liothyronine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Liothyronine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Liothyronine Market Size and Volume Forecast by Application
13.4.1. Chemical Reagents
13.4.2. Pharmaceutical Intermediates
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Liothyronine Market Size and Volume Forecast by Type
13.7.1. Purity 97%
13.7.2. Purity 98%
13.7.3. Purity 99%
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Liothyronine Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Liothyronine Market: Market Share Analysis
14.2. Liothyronine Distributors and Customers
14.3. Liothyronine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. TCI
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. HBCChem
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Toronto Research Chemicals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Waterstone Technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Alfa Aesar
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. 3B Scientific
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. VWR International
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Suzhou Ryan Pharmaceutical Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. J & K SCIENTIFIC
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Meryer Chemical Technology
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
